JAK inhibitors in RA: does their performance vary in the real world? @opal_ltd 🇦🇺: n= 5900 JAKi-treated RA pts, 2015-2021 upa is relatively new in Australia, but amazing how bari and tofa are so similar (same with the data on switching reason too) ABST0274 #ACR22 @RheumNow https://t.co/63PrRVAzk5